Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Tracheobronchial involvement of relapsing polychondritis.

de Montmollin N, Dusser D, Lorut C, Dion J, Costedoat-Chalumeau N, Mouthon L, Chassagnon G, Revel MP, Puéchal X.

Autoimmun Rev. 2019 Jul 16:102353. doi: 10.1016/j.autrev.2019.102353. [Epub ahead of print] Review.

PMID:
31323366
2.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM.

Ann Rheum Dis. 2019 May 15. pii: annrheumdis-2019-215213. doi: 10.1136/annrheumdis-2019-215213. [Epub ahead of print]

PMID:
31092409
3.

Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al.

Costedoat-Chalumeau N, Isenberg D, Petri M.

Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215573. doi: 10.1136/annrheumdis-2019-215573. [Epub ahead of print] No abstract available.

PMID:
31048291
4.

Women in internal medicine academic positions in France.

Cohen Aubart F, Roeser A, Costedoat-Chalumeau N, Papo T, Piette JC.

Eur J Intern Med. 2019 Jun;64:e18-e20. doi: 10.1016/j.ejim.2019.04.002. Epub 2019 Apr 10. No abstract available.

PMID:
30981614
5.

Acute pericarditis or a systemic disease with pleuropulmonary involvement?

Wu MA, Costedoat-Chalumeau N, Maestroni S, Brucato A.

Intern Emerg Med. 2019 Feb 21. doi: 10.1007/s11739-019-02057-9. [Epub ahead of print] No abstract available.

PMID:
30790197
6.

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.

Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón G, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet E.

Rheumatology (Oxford). 2019 Jul 1;58(7):1259-1267. doi: 10.1093/rheumatology/kez014.

PMID:
30753683
7.

Acute paraplegia due to schistosomiasis: an uncommon cause in developed countries.

Chauvin A, Ghazali A, Le Jeunne C, Plaisance P, Szwebel TA, Costedoat-Chalumeau N, Beubon F, Reiner P, Paugam A, Paule R.

J Neurovirol. 2019 Jun;25(3):434-437. doi: 10.1007/s13365-018-0713-6. Epub 2019 Jan 4.

PMID:
30610737
8.

Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study.

Grimaud F, Yelnik C, Pineton de Chambrun M, Amoura Z, Arnaud L, Costedoat Chalumeau N, Hachulla E, Lambert M, Roriz M, Sibilia J, Papo T, Sacre K.

Rheumatology (Oxford). 2019 Jun 1;58(6):1006-1010. doi: 10.1093/rheumatology/key437.

PMID:
30608611
9.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2019 Jul;78(7):1010-1012. doi: 10.1136/annrheumdis-2018-214434. Epub 2018 Dec 20. No abstract available.

10.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

11.

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

Johnson SR, Khanna D, Daikh D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, Hiepe F, Sánchez-Guerrero J, Massarotti E, Boumpas DT, Costenbader KH, Jayne D, Dörner T, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Aringer M.

J Rheumatol. 2019 Jul;46(7):721-726. doi: 10.3899/jrheum.180478. Epub 2018 Dec 15.

PMID:
30554156
12.

Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres.

Tani C, Elefante E, Martin-Cascón M, Belhocine M, Lavilla Olleros C, Vagelli R, Stagnaro C, Costedoat-Chalumeau N, Ruiz-Irastorza G, Mosca M.

Lupus Sci Med. 2018 Nov 2;5(1):e000274. doi: 10.1136/lupus-2018-000274. eCollection 2018.

13.

Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study.

Mirouse A, Seror R, Vicaut E, Mariette X, Dougados M, Fauchais AL, Deroux A, Dellal A, Costedoat-Chalumeau N, Denis G, Sellam J, Arlet JB, Lavigne C, Urbanski G, Fischer-Dumont D, Diallo A, Fain O, Mékinian A; Club Rhumatismes Inflammation and SNFMI.

Autoimmun Rev. 2019 Jan;18(1):9-14. doi: 10.1016/j.autrev.2018.06.015. Epub 2018 Nov 5. Review.

PMID:
30408585
14.

Relapsing polychondritis: state of the art on clinical practice guidelines.

Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, Launay D, Mathian A, Mattews L, Ponte C, Toniati P, Bombardieri S, Frank C, Schneider M, Smith V, Cutolo M, Mosca M, Arnaud L.

RMD Open. 2018 Oct 18;4(Suppl 1):e000788. doi: 10.1136/rmdopen-2018-000788. eCollection 2018.

15.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

16.

Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women.

Belhocine M, Coutte L, Martin Silva N, Morel N, Guettrot-Imbert G, Paule R, Le Jeunne C, Fredi M, Dreyfus M, Piette JC, Souchaud-Debouverie O, Deneux-Tharaux C, Tsatsaris V, Pannier E, Le Guern V, Costedoat-Chalumeau N.

Arthritis Res Ther. 2018 Nov 6;20(1):249. doi: 10.1186/s13075-018-1745-2.

17.

Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.

Barsalou J, Costedoat-Chalumeau N, Berhanu A, Fors-Nieves C, Shah U, Brown P, Laskin CA, Morel N, Levesque K, Buyon JP, Silverman ED, Izmirly PM.

Ann Rheum Dis. 2018 Dec;77(12):1742-1749. doi: 10.1136/annrheumdis-2018-213718. Epub 2018 Oct 8.

18.

Ustekinumab: a promising new drug for SLE?

Costedoat-Chalumeau N, Houssiau FA.

Lancet. 2018 Oct 13;392(10155):1284-1286. doi: 10.1016/S0140-6736(18)32330-4. Epub 2018 Sep 21. No abstract available.

PMID:
30249508
19.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Aug 6. doi: 10.1002/cpt.1194. [Epub ahead of print]

PMID:
30079582
20.

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.

Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri JL, Guerra MM, Laskin CA, Branch DW, Sammaritano LR, Morel N, Guettrot-Imbert G, Launay D, Hachulla E, Hatron PY, Salmon JE, Costedoat-Chalumeau N.

Lupus. 2018 Sep;27(10):1679-1686. doi: 10.1177/0961203318787032. Epub 2018 Jul 17.

PMID:
30016929
21.

Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.

Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, Mouthon L, le Jeunne C, Chauvin A, Piette JC, Costedoat-Chalumeau N.

Autoimmun Rev. 2018 Sep;17(9):866-872. doi: 10.1016/j.autrev.2018.03.011. Epub 2018 Jul 10. Review.

PMID:
30005859
22.

Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.

Dollat M, Chaigne B, Cormier G, Costedoat-Chalumeau N, Lifermann F, Deroux A, Berthoux E, Dernis E, Sené T, Blaison G, Lambotte O, Terrier B, Sellam J, De Saint-Martin L, Chiche L, Dupin N, Mouthon L.

BMC Infect Dis. 2018 Jul 4;18(1):302. doi: 10.1186/s12879-018-3227-1.

23.

[How to minimize the risk of infection in systemic lupus erythematosus?]

Costedoat-Chalumeau N, Groh M, Piette JC, Launay O.

Rev Med Interne. 2019 Jun;40(6):347-350. doi: 10.1016/j.revmed.2018.06.002. Epub 2018 Jun 22. French. No abstract available.

PMID:
29937299
24.

Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.

Fredi M, Andreoli L, Aggogeri E, Bettiga E, Lazzaroni MG, Le Guern V, Lojacono A, Morel N, Piette JC, Zatti S, Costedoat-Chalumeau N, Tincani A.

Front Immunol. 2018 May 7;9:864. doi: 10.3389/fimmu.2018.00864. eCollection 2018.

25.

Disease severity of proliferative lupus nephritis in Maghrebians.

Tamirou F, Costedoat-Chalumeau N, Medkouri G, Daugas E, Hachulla E, Jourde-Chiche N, Karras A, le Guern V, Gnemmi V, Jadoul M, Houssiau FA.

Lupus. 2018 Jul;27(8):1387-1392. doi: 10.1177/0961203318772016. Epub 2018 Apr 27.

PMID:
29703123
26.

Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.

Moulis G, Pugnet G, Costedoat-Chalumeau N, Mathian A, Leroux G, Boutémy J, Espitia O, Bouillet L, Berthier S, Gaultier JB, Jeandel PY, Konaté A, Mékinian A, Solau-Gervais E, Terrier B, Wendling D, Andry F, Garnier C, Cathébras P, Arnaud L, Palmaro A, Cacoub P, Amoura Z, Piette JC, Arlet P, Lapeyre-Mestre M, Sailler L.

Ann Rheum Dis. 2018 Aug;77(8):1172-1178. doi: 10.1136/annrheumdis-2017-212705. Epub 2018 Mar 13.

PMID:
29535124
27.

mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G.

Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group.

Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017.

PMID:
29506143
28.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA.

Thromb Haemost. 2018 Apr;118(4):639-646. doi: 10.1055/s-0038-1632388. Epub 2018 Feb 28.

29.

Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.

Serris A, Amoura Z, Canouï-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg JE, Godeau B, Michel M.

Am J Hematol. 2018 Mar;93(3):424-429. doi: 10.1002/ajh.24999. Epub 2018 Jan 25.

30.

News on Relapsing Polychondritis: The Patient's Experience.

Piette JC, Dion J, Costedoat-Chalumeau N.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1121-1123. doi: 10.1002/acr.23490. No abstract available.

PMID:
29245187
31.

[Chronic histiocytic intervillositis: Diagnosis and management].

Mekinian A, Costedoat-Chalumeau N, Carbillon L, Coulomb-L'Hermine A, Le Guern V, Masseau A, Lazaro E, Cohen J, Bornes M, Kayem G, Fain O.

Rev Med Interne. 2018 Feb;39(2):117-121. doi: 10.1016/j.revmed.2017.10.422. Epub 2017 Nov 13. French.

PMID:
29146013
32.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

33.

Treatment adherence in systemic lupus erythematosus and rheumatoid arthritis: time to focus on this important issue.

Costedoat-Chalumeau N, Tamirou F, Piette JC.

Rheumatology (Oxford). 2018 Sep 1;57(9):1507-1509. doi: 10.1093/rheumatology/kex337. No abstract available.

PMID:
28968691
34.

Reply.

Dion J, Costedoat-Chalumeau N, Piette JC.

Arthritis Rheumatol. 2018 Jan;70(1):149. doi: 10.1002/art.40329. Epub 2017 Nov 28. No abstract available.

35.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Van Vollenhoven R, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Jun;103(6):1074-1082. doi: 10.1002/cpt.885. Epub 2017 Nov 9.

36.

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. eCollection 2017.

37.

Should we treat congenital heart block with fluorinated corticosteroids?

Brucato A, Tincani A, Fredi M, Breda S, Ramoni V, Morel N, Costedoat-Chalumeau N.

Autoimmun Rev. 2017 Nov;16(11):1115-1118. doi: 10.1016/j.autrev.2017.09.005. Epub 2017 Sep 9. Review. No abstract available.

PMID:
28899797
38.

[Relapsing polychondritis: What's new in 2017?]

Dion J, Leroux G, Mouthon L, Piette JC, Costedoat-Chalumeau N.

Rev Med Interne. 2018 Jun;39(6):400-407. doi: 10.1016/j.revmed.2017.07.008. Epub 2017 Sep 8. Review. French.

PMID:
28890262
39.

Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus.

Morel N, Lévesque K, Maltret A, Baron G, Hamidou M, Orquevaux P, Piette JC, Barriere F, Le Bidois J, Fermont L, Fain O, Theulin A, Sassolas F, Hauet Q, Guettrot-Imbert G, Georgin-Lavialle S, Deligny C, Hachulla E, Mouthon L, Le Jeunne C, Ravaud P, Le Mercier D, Romefort B, Villain E, Bonnet D, Costedoat-Chalumeau N; “Lupus néonatal” group.

Int J Cardiol. 2017 Dec 1;248:263-269. doi: 10.1016/j.ijcard.2017.07.100. Epub 2017 Aug 7.

PMID:
28843719
40.

Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN).

Savey L, Piette JC, Bellanger J, Palazzo L, Amoura Z, Sauvanet A, Pouget-Abadie JF, Sogni P, Emmerich J, Costedoat-Chalumeau N.

Semin Arthritis Rheum. 2018 Feb;47(4):565-568. doi: 10.1016/j.semarthrit.2017.07.001. Epub 2017 Jul 10.

PMID:
28802775
41.

Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study.

Grabar S, Groh M, Bahuaud M, Le Guern V, Costedoat-Chalumeau N, Mathian A, Hanslik T, Guillevin L, Batteux F, Launay O; VACCILUP study group.

Vaccine. 2017 Sep 5;35(37):4877-4885. doi: 10.1016/j.vaccine.2017.07.094. Epub 2017 Aug 4.

PMID:
28784280
42.

Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature.

André R, Cottin V, Saraux JL, Blaison G, Bienvenu B, Cathebras P, Dhote R, Foucher A, Gil H, Lapoirie J, Launay D, Loustau V, Maurier F, Pertuiset E, Zénone T, Seebach J, Costedoat-Chalumeau N, Puéchal X, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG).

Autoimmun Rev. 2017 Sep;16(9):963-969. doi: 10.1016/j.autrev.2017.07.007. Epub 2017 Jul 12. Review.

PMID:
28709761
43.

Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients.

Mekinian A, Dervin G, Lapidus N, Kahn JE, Terriou L, Liozon E, Grignano E, Piette JC, Rauzy OB, Grobost V, Godmer P, Gillard J, Rossignol J, Launay D, Aouba A, Cardon T, Bouillet L, Broner J, Vinit J, Ades L, Carrat F, Salvado C, Toussirot E, Versini M, Costedoat-Chalumeau N, Fraison JB, Guilpain P, Fenaux P, Fain O; GFM, SNFMI, CRI and MINHEMON.

Autoimmun Rev. 2017 Sep;16(9):903-910. doi: 10.1016/j.autrev.2017.07.003. Epub 2017 Jul 10.

PMID:
28705782
44.

Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey.

Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, Cacoub P, Jourde-Chiche N, Urbanski G, Augusto JF, Moulis G, Raffray L, Deroux A, Hummel A, Lioger B, Catroux M, Faguer S, Goutte J, Martis N, Maurier F, Rivière E, Sanges S, Baldolli A, Costedoat-Chalumeau N, Roriz M, Puéchal X, André M, Lavigne C, Bienvenu B, Mekinian A, Zagdoun E, Girard C, Bérezné A, Guillevin L, Thervet E, Pillebout E; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Sep;69(9):1862-1870. doi: 10.1002/art.40178.

45.

Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.

Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A.

J Rheumatol. 2017 Aug;44(8):1165-1172. doi: 10.3899/jrheum.161364. Epub 2017 Jun 1.

PMID:
28572466
46.

Cardiac sarcoidosis: Diagnosis, therapeutic management and prognostic factors.

Chapelon-Abric C, Sene D, Saadoun D, Cluzel P, Vignaux O, Costedoat-Chalumeau N, Piette JC, Cacoub P.

Arch Cardiovasc Dis. 2017 Aug - Sep;110(8-9):456-465. doi: 10.1016/j.acvd.2016.12.014. Epub 2017 May 26.

47.

Bone marrow involvement in systemic lupus erythematosus.

Chalayer E, Costedoat-Chalumeau N, Beyne-Rauzy O, Ninet J, Durupt S, Tebib J, Asli B, Lambotte O, Ffrench M, Vasselon C, Cathébras P.

QJM. 2017 Nov 1;110(11):701-711. doi: 10.1093/qjmed/hcx102.

PMID:
28525589
48.

Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.

Gavand PE, Serio I, Arnaud L, Costedoat-Chalumeau N, Carvelli J, Dossier A, Hinschberger O, Mouthon L, Le Guern V, Korganow AS, Poindron V, Gourguechon C, Lavigne C, Maurier F, Labro G, Heymonet M, Artifoni M, Viau AB, Deligny C, Sene T, Terriou L, Sibilia J, Mathian A, Bloch-Queyrat C, Larroche C, Amoura Z, Martin T.

Autoimmun Rev. 2017 Jul;16(7):743-749. doi: 10.1016/j.autrev.2017.05.010. Epub 2017 May 5. Review.

PMID:
28483541
49.

Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.

Mekinian A, Alijotas-Reig J, Carrat F, Costedoat-Chalumeau N, Ruffatti A, Lazzaroni MG, Tabacco S, Maina A, Masseau A, Morel N, Esteve-Valverde EE, Ferrer-Oliveras R, Andreoli L, De Carolis S, Josselin-Mahr L, Abisror N, Nicaise-Roland P, Tincani A, Fain O; on the behalf of the SNFMI and the European Forum on Antiphospholipid Antibodies.

Autoimmun Rev. 2017 Jul;16(7):730-734. doi: 10.1016/j.autrev.2017.05.006. Epub 2017 May 4. Review.

PMID:
28478081
50.

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.

Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.

PMID:
28434948

Supplemental Content

Loading ...
Support Center